SEP 9, 2026 · PHASE 1/2 TRIAL
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
ClinicalTrials.gov
This is an active Phase 1/2 trial registration with no results posted; enrollment is complete but outcomes have not been reported in this registry record.
Reported
Enrollment (actual)74
Study phasePhase 1/Phase 2
Primary outcome measureObjective response (OR) by investigator ass…